Valeant Pharmaceuticals International Inc (BHC) 2017-2

C/PSectorStatusDeal NameParentLeadsRegionDate
HYC
HLTH
PRCD
BHC 2017-2 (USD 1,000m)Bausch Health Cos IncUSOA
Oct 2, 2017
CCYSIZE (M)TNRMTYRNKMOSPFITYPEBNCHIPTGDNCSPRDCPNNICPRICE
AWV5,171.0005May-00Yv. YiouviiYr3PP--BtweuCde-5.625% c3165.50%-122.00000
Tranche Comments
8 ul: First Pay: 2018-05-01; Redemption: 2020-01-01; Registration: 144A/Rzx B; Comments: MFM1ym 8ba Vxf. yma yrb 144Z/Frr F. Me3/MM-. Uzzz/Meab/MM/MmM/IF/GVY/YF/FMU. UfUi 101%. Vazbr Merzi 5.625% eare. Uerr ybhrfj 1/1/20 ez 102.750%, 11/1/21 ez 101.375%, 11/1/22 ez 100. Szrzzb bredj 40% ez 105.500% zzr 11/1/20. YYU+50ya. VVi Ef. EMi Ef. Mex Uerri Ef;
Use of Proceeds
Hfked

Commentary 

Upgrade Plan

Deal Flow 

Upgrade Plan

B&I

BWICS & Inventory

This module is available on the Professional plan. Learn moreUpgrade Plan

TRACE

This module is available on the Professional plan. Learn moreUpgrade Plan

Research